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Abstract  The  presence  of  fat  within  a  hepatic  lesion  is  unusual  and  can  help  to  direct  the
radiologist’s  diagnosis.  The  aim  of  this  iconographic  review  is  to  specify  the  various  hepatic
lesions that  may  contain  fat  and  their  appearance  particularly  on  MRI.  A  histological  correlation
is also  suggested  for  the  most  commonly  found  tumors.  The  identiﬁcation  of  fat  within  a  hepatic
tumor, along  with  other  radiological  signs  and  reﬂection  on  the  clinical  and  epidemiological
context, can  lead  to  a  diagnosis  being  reached  or  suggested,  with  conﬁrmation  if  necessary,  by
a pathological  examination.
©  2013  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
The  presence  of  fat  in  a  liver  lesion  is  not  a  standard  ﬁnding  and  it  can  help  to  guide
the  radiologist  towards  a  diagnosis.  Fat  may  be  macroscopic  or  microscopic.  MRI  is  the
modality  of  choice  for  detecting  a  fatty  component  in  a  hepatic  tumor:  fat-saturation
sequence  detects  extracellular  fat  while  chemical  shift  imaging  identiﬁes  microscopic  or
intracellular  lipids  [1].
Once  intracellular  lipids  are  demonstrated,  this  allows  a  range  of  diagnoses  to  be  consid-
ered,  including  multifocal  hepatic  steatosis,  focal  nodular  hyperplasia  (FNH),  adenomas,
hepatocellular  carcinoma,  and  some  hepatic  metastases.By  contrast,  the  presence  of  fat  in  a tumor  that  is  not  within  the  hepatocytes  is  sug-
gestive  of  angiomyolipoma,  pseudolipoma  of  the  Glisson  capsule,  fat  deposits  around  the
intrahepatic  wall  of  the  inferior  vena  cava  or  ‘‘pericaval  fat’’,  hydatid  cyst,  teratoma,
liposarcoma  and  some  metastases  [2,3].
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is  needed,  and  contraception  does  not  need  to  be  discon-02  
iver lesions containing intracellular fat
hen  steatosis  is  demonstrated  within  a  focal  hepatic  lesion
hrough  signal  drop  on  the  out-of-phase  sequence,  the  fol-
owing  diagnoses  should  be  the  ﬁrst  to  come  to  mind:  focal
teatosis,  focal  nodular  hyperplasia,  HNF1 mutated  ade-
oma,  inﬂammatory  hepatic  adenoma,  and  hepatocellular
arcinoma.
The  next  stage  in  the  diagnostic  process  for  the  radiolo-
ist  is  to  determine  whether  the  steatosis  within  the  tumor
s  homogeneous  and  diffuse  or  focal,  and  whether  or  not  the
esion  is  hypervascularised,  and,  if  relevant,  whether  there
s  contrast  washout.  These  features,  taken  together  with
 study  of  the  adjacent  parenchyma  and  the  context,  will
sually  allow  a  diagnosis  to  be  made  or  strongly  suspected.
ocal pseudo-nodular steatosis
he  conditions  under  which  hepatic  steatosis  is  most  often
ound  are  excessive  alcohol  consumption,  insulin  resistance,
besity,  hyperlipidaemia,  hepatitis  B  and  C  infection,  and
he  use  of  certain  medications.  Hepatic  steatosis  is  the
esult  of  a  build-up  of  fat  vacuoles  in  the  hepatocytes,  and
t  can  be  diffuse,  focal,  or  multifocal  (Fig.  1).  Focal  pseudo-
odular  hepatic  steatosis  can  be  mistaken  for  a  focal  lesion
n  sonography  or  CT  [4].  Areas  of  focal  hepatic  steatosis  are
sually  found  in  the  periportal  region,  in  contact  with  the
igure 1. Focal steatosis mimicking a tumor (*) in the left lobe and segm
nd hypertrophy of the caudate lobe (arrow heads). These areas of stea
c), with a marked signal drop on the out-of-phase sequence (b). With c
rterial phase (d) and slight low signal intensity in the portal (e) and de
ithout displacement.
t
t
lM.  Tekath  et  al.
alciform  ligament  or  the  gall  bladder.  This  positioning  is  due
o  variations  in  venous  ﬂow  within  the  hepatic  parenchyma,
esulting  from  the  links  to  the  vascular  networks  of  the  pan-
reas  and  duodenum,  gall  bladder,  and  digestive  system  [5].
nsulin  has  also  been  suggested  to  play  a  role  due  to  steatosis
eing  demonstrated  in  contact  with  insulinoma  metastases
6].
Chemical  shift  imaging  shows  fat  present  in  the  hepato-
ytes  with  a  signal  drop  on  the  out-of-phase  sequence.  This
nding,  when  seen  together  with  a  characteristic  location,
 lack  of  mass  effect,  geographic  borders,  and  a  parallel
nhancement  gradient  to  that  of  the  adjacent  parenchyma,
llows  the  diagnosis  to  be  made  with  certainty  [6].
ocal nodular hyperplasia
his  is  the  most  commonly  seen  benign  tumor  of  the  hepato-
ytes,  with  an  estimated  prevalence  of  9/1000  and  a  female
o  male  ratio  of  8:1  [7]. FNH  is  thought  to  be  an  abnor-
al  proliferation  of  the  hepatic  parenchyma  in  response
o  a  congenital  vascular  malformation.  It  is  usually  discov-
red  incidentally  or  further  to  non-speciﬁc  symptoms.  It  is
ssential  to  identify  FNH  correctly  because  no  monitoringent I in a patient with chronic liver disease with indented contours
tosis appear in iso-signal on in-phase T1 images (a) and T2 images
ontrast enhancement, these areas have iso-signal intensity in the
layed phases (f). There are vessels coursing through these areas,
inued.  MRI  is  the  most  sensitive  modality  for  diagnosis  of
his  condition  [8].  Typically,  FNH  is  a well-circumscribed,
obulated  lesion  with  no  capsule,  with  iso-  or  low  signal
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intensity  on  T1-weighted  sequences,  iso-  or  slight  high  signal
intensity  on  T2-weighted  sequences,  that  is  usually  homo-
geneous,  but  can  be  non-homogeneous  if  the  lesion  is  large.
There  is  a  characteristic  central  scar  (or  area  of  ﬁbrosis),
especially  in  lesions  larger  than  2  cm.  It  presents  intense
arterial  phase  enhancement  and  becomes  iso-intense  to
the  adjacent  parenchyma  in  the  portal  phase.  The  central
area  of  ﬁbrosis  shows  low  signal  intensity  on  T1-weighted
sequences,  high  signal  intensity  on  T2-weighted  sequences,
with  delayed  phase  enhancement.
While  intracellular  lipids  are  possible  in  FNH,  this  is
an  atypical  ﬁnding.  The  frequency  of  this  feature  varies
enormously  between  studies,  ranging  from  22—85%  [8—10].
There  is  probable  overestimation  due  to  these  being  lesions
that  have  undergone  biopsy  or  resection  because  of  their
atypical  appearance  on  imaging.
Intratumoral  steatosis  (Fig.  2)  is  shown  by  a  signal
drop  on  out-of-phase  T1-weighted  images.  This  does  not
always  equate  to  an  atypical  appearance  on  MRI  if  the
other  criteria  are  brought  together.  It  can,  however,
lead  to  difﬁculties  in  diagnosis,  especially  in  making  the
distinction  from  the  differential  diagnosis  of  inﬂamma-
tory  hepatic  adenoma  [9].  The  use  of  hepatocyte-speciﬁc
contrast  agents  can  give  weight  to  diagnosis  in  these
instances.  In  this  respect,  Grazioli  et  al.  [11]  showed
that  over  96%  of  FNH  demonstrated  iso-  or  high  signal
s
c
f
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Figure 2. MRI of FNH with fat content. Well-circumscribed lesion at th
intensity on T2 (a), iso-signal intensity on in-phase T1 (b) outside the c
signal intensity on out-of-phase T1 images (c). With gadolinium enhanc
central scar showing low signal intensity (*) and enhancement in the del
shows an area of inﬂammatory ﬁbrous septa (*) containing bile ducts in t
hepatocytes (arrows).203
ntensity  in  a  late  delayed  phase  (after  1—3  h)  follow-
ng  administration  of  gadobenate  dimeglumine,  while  100%
f  adenomas  showed  low  signal  intensity.  More  recently,
he  use  of  gadoxetic  acid  has  been  evaluated  [12]  to
tudy  the  dynamic  contrast  enhancement  patterns  of
esions,  focusing  particularly  on  an  acquisition  taken  20  min
fter  administration  (hepatobiliary  phase).  In  this  study,
1.2%  of  FNH  showed  iso-  or  slight  high  signal  intensity
ompared  to  the  adjacent  parenchyma  20  min  after  admin-
stration.  In  cases  with  atypical  enhancement  patterns,  a
arge  central  scar  or  an  abundant  fatty  component  was
oted.
epatocellular adenomas (HCA)
epatocellular  adenomas  are  uncommon  benign  tumors  with
n  estimated  prevalence  of  0.03%  and  a  female  to  male  ratio
f  9:1.  Adenomas  are  usually  diagnosed  in  young  women
f  childbearing  age,  who  are  often  found  to  be  using  oral
ontraception.  Histologically,  this  tumor  corresponds  to  a
enign  proliferation  of  normal  hepatocytes  without  portal
racts  [13]. It  is  crucial  to  make  or  suggest  the  diagno-
is  of  adenoma  on  imaging  due  to  its  potentially  serious
omplications  [14]:  haemorrhage  (20%  of  cases),  and  trans-
ormation  to  hepatocellular  carcinoma  (10%).  The  latter  is
 particular  risk  for  men,  with  47%  affected  compared  to  4%
e junction of segments VI and VII (arrow) showing slight high signal
entral scar, which shows low signal intensity (*), and marked low
ement, there is contrast uptake in the arterial phase (d) with the
ayed phase (e). On histology (f), H and E stain enlarged 100 times
he centre of the lesion, around which are vacuolated and steatotic
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f  women  [15].  The  lesion  can  be  single  or  multiple.  The  risk
f  progression  does  not  correlate  to  the  number  of  lesions,
ut  to  their  sub-type.
Recent  advances  in  cytogenetics  and  molecular  biol-
gy  have  led  to  four  sub-types  of  hepatocellular  adenoma
eing  identiﬁed:  HNF1 mutated  adenoma,  inﬂammatory
denoma,  -catenin  mutated  adenoma,  and  unclassiﬁed
denomas  [16—18].  Each  type  has  a  speciﬁc  set  of  features
n  MRI  [19,20],  which  means  that  this  modality  has  increased
peciﬁcity  for  the  diagnosis  of  HNF1 mutated  and  inﬂam-
atory  adenomas  [19,21].  It  is  essential  to  identify  the
ub-type  of  HCA  because  each  one  has  speciﬁc  complications
nd  different  management  is  needed  as  a  result.  The  two
ost  common  sub-types  are  HNF1 mutated  adenoma  andnﬂammatory  adenoma,  both  of  which  can  contain  intracel-
ular  fat.
T
w
igure 3. Example of a female with steatotic adenomas (arrows) sho
lear low signal on T1 (*) on the out-of-phase sequence (c). These lesion
ntensity that persists into the portal (e) and delayed phases (f). Histol
ade up of narrow sheets of hepatocytes with cytoplasm occupied by lar
f healthy liver (arrowheads), and note that none of the hepatocytes heM.  Tekath  et  al.
NF1  (hepatocyte  nuclear  factor  1  alpha)
utated adenoma
NF1 (hepatocyte  nuclear  factor  1  alpha)  mutated  ade-
oma  (Fig.  3)  accounts  for  30—46%  of  HCA,  depending  on
he  study.  Histologically,  it  is  characterised  by  an  absence  of
ytologic  atypia  and  inﬂammatory  inﬁltrate,  while  there  is
iffuse  and  homogeneous  steatosis.  These  features  explain
ts  appearance  on  imaging.  Thus,  MRI  will  show  a  lesion  with
igh  signal  intensity  on  T1-weighted  in-phase  sequences
ith  a  uniform  signal  drop  on  out-of-phase  imaging.  On  T2-
eighted  sequences,  the  tumor  will  show  iso-  or  slight  high
ignal  intensity.  After  administration  of  gadolinium  chelates,
nhancement  is  moderate  or  even  absent  in  the  arterial
hase,  and  does  not  persist  into  the  portal  or  delayed  phase.
he  main  differential  diagnosis  is  hepatocellular  carcinoma
ith  fat  content.
wing slight high signal intensity on T2 (a), iso-signal on T1 (b) and
s enhance moderately during the arterial phase (d) with low signal
ogy, H and E stain, enlarged 12.5 times (g), shows an adenoma (*)
ge vacuoles of steatosis. On the left of the image, a displaced band
re show steatosis.
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There  is  no  risk  of  malignant  transformation  in  HNF1
mutated  adenomas,  and  the  risk  of  haemorrhage  is  low  but
it  increases  with  lesion  size.
Inﬂammatory  hepatic  adenoma
Inﬂammatory  hepatic  adenoma,  previously  known  as  telang-
iectatic  FNH,  accounts  for  40—55%  of  HCA.  It  is  clinically
associated  with  obesity,  hepatic  steatosis,  and,  in  terms  of
laboratory  study  signs,  raised  inﬂammatory  markers.  Intra-
cellular  fat  in  the  tumor  is  noted  in  11%  of  cases  [18]. In
contrast  to  HNF1 mutated  adenoma,  steatosis  within  the
tumor  is  often  focal  and  heterogeneous.  However,  Ronot
et  al.  [21]  report  the  presence  of  diffuse  steatosis  in  21%
of  cases  of  inﬂammatory  hepatic  adenoma  although  it  was
still  non-homogeneous  (while  it  was  homogeneous  in  HNF1
mutated  adenoma).
In  histological  terms,  inﬂammatory  adenoma  is  char-
acterised  by  the  presence  of  inﬂammatory  inﬁltrates,
dystrophic  vessels,  and  dilated  sinusoids.  A  small  num-
ber  (5—10%)  can  present  -catenin  activation  and  progress
to  hepatocellular  carcinoma  [17].  There  is  greater  risk  of
haemorrhage  than  in  HNF1 mutated  adenomas.MRI  most  often  demonstrates  a  lesion  with  iso-signal
intensity  on  T1-weighted  sequences,  with  focal  areas  of
signal  drop  on  out-of-phase  images  if  there  is  an  intracellu-
lar  fat  component.  There  is  marked  high  signal  intensity  on
U
U
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Figure 4. MRI of a hepatocellular adenoma that is unclassiﬁed on imagin
on T2 fat-sat (a), iso-signal on in-phase T1 (b) with moderate signal drop
contrast uptake (arrow head) in the arterial phase (d) with homogeneo
stain, enlarged 12.5 times (f), points to a -catenin mutated adenoma (*)
thin, there is no portal tract within the lesion, and dilated sinusoid capill
the healthy parenchyma is displaced (arrow heads).205
2-weighted  images  due  to  the  dilated  sinusoids.  Arterial
hase  enhancement  is  intense  and  persists  into  the  portal
nd  delayed  phases.  The  atoll  sign  is  seen  in  43%  of  cases
20], corresponding  to  a  peripheral  band  of  high  signal
ntensity  on  T2-weighted  sequences  with  delayed  phase
nhancement,  while  the  lesion  centre  is  iso-intense.
-catenin  activated  adenomas
-catenin  activated  adenomas  are  less  common;  more  often
ound  in  men  [15],  and  account  for  10%  of  HCA.  Cytologic
typia  and  a  pseudoglandular  growth  pattern  may  be  seen.
Although  it  has  a varying  appearance  on  imaging,  a  fatty
omponent  within  the  lesion  has  never  been  demonstrated.
his  is  a  heterogeneous  lesion  on  all  sequences,  showing
so-signal  intensity  on  T1-  and  T2-weighted  sequences,  with
rterial  phase  enhancement  and  washout  following  admin-
stration  of  gadolinium  chelates.  A  central  scar  is  possible,
eing  seen  in  75%  of  cases,  which  will  show  high  signal  inten-
ity  on  T2-weighted  sequences,  but  this  is  not  a speciﬁc  sign
ince  it  can  also  been  seen  in  other  adenoma  sub-types.
-catenin  mutated  adenoma  is  associated  with  an
ncreased  risk  of  malignant  transformation  [16].nclassiﬁed  adenomas
nclassiﬁed  adenomas  (Fig.  4)  are  a  group  of  lesions  that
o  not  present  speciﬁc  features  in  terms  of  morphology  or
g (arrow) of the left liver lobe showing non-homogeneous iso-signal
 (*) on the out-of-phase sequence (c). There is a minimally intense
us low signal intensity in the portal phase (e). Histology, H and E
 with no steatotic component; the sheets of tumor hepatocytes are
aries can be seen in the central part of the adenoma. Peripherally,
2i
r
H
H
i
a
h
p
o
c
[
t
b
I
r
i
b
i
b
s
t
l
t
d
E
A
M
a
p
s
p
v
t
r
n
w
s
u
e
F
o
e
(06  
mmunophenotype.  Steatosis  within  the  lesion  has  not  been
eported  in  this  adenoma  sub-type.
epatocellular carcinoma (HCC)
CC  is  the  most  common  primary  hepatic  tumor,  developing
n  a  cirrhotic  liver  in  80%  of  cases  [22].  This  lesion  produces
 variable  signal  on  T1-  and  T2-weighted  sequences,  with
ypervascularisation  in  the  arterial  phase  and  washout  in  the
ortal  and/or  delayed  phase.  In  bulky  tumors,  the  presence
f  a  capsule  and  mosaic  perfusion  is  possible.  The  diagnostic
riteria  for  HCC  in  a  cirrhotic  liver  were  amended  in  2011
23]:  the  diagnosis  can  be  conﬁrmed  on  CT  or  MRI  for  any
umor  larger  than  1  cm  if  there  is  arterialisation  and  visi-
le  contrast  washout  in  the  portal  and/or  delayed  phase.
ntracellular  fat  is  not  an  uncommon  ﬁnding  (Fig.  5),  being
eported  in  19.6%  of  cases  [24].  Steatosis  within  the  lesion
s  mainly  seen  in  small  low-grade  lesions  (particularly  those
etween  1  and  1.5  cm  in  diameter).  This  intracellular  fat
s  common  and  diffuse  in  well-differentiated  HCC  (42%).  It
ecomes  less  common  and  more  focal  as  the  grade  and  tumor
ize  increase.  In  one  study,  Katumi  et  al.  [24]  reported  that
he  presence  of  a  capsule  was  rare  in  HCC  with  intracellu-
ar  fat  content  (absent  in  81%  of  cases).  This  feature  can  be
v
n
m
igure 5. HCC of the dome of the liver (arrow) with a high intracellu
n in-phase T1 (a), with a marked signal drop (*) on the out-of-phase
nhancement pattern is also typical of HCC with marked arterialisation (
f).M.  Tekath  et  al.
he  cause  of  difﬁculties  in  making  the  distinction  with  the
ifferential  diagnosis  of  HNF1 mutated  adenoma.
xtracellular fat-containing liver lesions
ngiomyolipoma
ore  commonly  seen  in  the  kidneys,  sporadic  hepatic
ngiomyolipoma  is  rare,  with  an  increased  frequency  in
atients  with  tuberous  sclerosis.
It is  a  benign  lesion  made  up  of  smooth  muscle  cells,  ves-
els,  and  adipocytes.  There  is  signiﬁcant  variability  in  the
roportions  of  these  three  components,  resulting  in  equally
ariable  appearances  on  imaging,  which  makes  preopera-
ive  diagnosis  rare.  The  proportion  of  fat  in  particular  can
ange  from  under  10%  to  over  90%  [25].  Typically,  the  lesion  is
on-homogeneous,  with  variable  high  signal  intensity  on  T2-
eighted  sequences,  high  signal  intensity  on  T1-weighted
equences,  and  a  signal  drop  on  fat-suppressed  images.  With
se  of  a  contrast  agent,  it  demonstrates  non-homogeneous
nhancement  that  occurs  early  and  persists,  showing  that
essels  are  present  in  and  around  the  tumor  [25].
A  small  series  of  cases  [26]  of  atypical  AML  (Fig.  6)  with
o  fat  component  brings  together  the  various  enhance-
ent  characteristics,  still  showing  non-homogeneous
lar fat component. The lesion presents slight high signal intensity
 T1 sequence (b) and high signal intensity on T2 fat-sat (c). The
arrowheads) (d), then washout in the portal (e) and delayed phases
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Figure 6. A well-circumscribed angiomyolipoma with heterogeneous high signal intensity on T2 (a), clear low signal intensity on in-phase
T1 images (b) outside a central zone (*) that shows slight high signal intensity with signal drop (arrowheads) on out-of-phase T1 sequences
(c) and T1 fat-sat (d). After contrast material administration, the tumor shows intense enhancement in the arterial phase (e) with rapid
and heterogeneous washout in the portal (f) and delayed phases (g). Note the visualisation of the vessels in and around the lesion (arrows).
Immunohistochemistry, enlarged 200 times (h), shows that some of the tumor cells express actin with variable intensity (brown staining).
The contrasting stain (pale blue) allows the majority of the smooth muscle cells to be drawn out as epithelioid, as well as showing the
adipocytes, which seem to have empty cytoplasm under the microscope. Enlarged 40 times, HE staining (i) shows the lesion to have tree-like
vasculature (arrowheads).
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rterialisation  but  with  washout  in  the  portal  phase  and
elayed  phase,  no  ﬁbrous  capsule,  and  vessels  present  in
nd  around  the  tumor.
ericaval fat collectionhis  is  a  rare  and  benign  type  of  fat  formation  that  develops
n  contact  with  the  endoluminal  side  of  the  inferior  vena
ava  wall  (Fig.  7).  This  ‘‘incidentaloma’’  increases  in
T
I
f
igure 7. MRI showing pericaval fat developed in a cirrhotic liver. Thi
2 imaging (a), in-phase (b) and out-of-phase T1 imaging (c). It is visible 
t remains in clear low signal intensity (*) on T1 fat-sat contrast-enhanc
ith enhancement of the inferior vena cava at its periphery (black arrow
igament due to cirrhosis, and an unremarkable biliary cyst in segment IV
xial view of the same patient.M.  Tekath  et  al.
requency  in  patients  with  chronic  liver  disease  and  it  must
ot  be  mistaken  for  a  neoplasm  or  a  thrombus  [27].
seudolipoma of the Glisson capsulehis  is  an  asymptomatic  lesion  that  is  an  incidental  ﬁnding.
t  is  well-circumscribed,  sub-capsular,  and  presents  purely
atty  density  (Fig.  8).
s lesion (white arrow) is indistinguishable from the adjacent fat on
because of a marked signal drop (*) on the T2 fat-sat sequence (d).
ed sequences in the arterial (e), portal (f), and delayed phases (g)
heads). Note the presence of ascites, recanalisation of the round
. The pericaval fat (arrow) is more easily seen on CT (h): note this
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Figure 8. Pseudolipoma of the Glisson capsule (arrow) adjacent to segment I. It was an incidental ﬁnding on an emergency CT to investigate
a gynaecological haemorrhage. On axial (a—c) and coronal (d—f) reconstructions, this lesion is hypodense with fatty density, homogenous,
sub-capsular, and there is no contrast uptake in either the arterial (b, e) or portal phases (c, f). Note the abundant haemoperitoneum (*).
h
c
ence  of  a fat-ﬂuid  level  within  a  hydatid  cyst  is  not  usualHydatid cyst
Echinococcosis  is  a  zoonotic  disease  caused  by  Echinococcus
ganulosis  and  E.  multilocularis  infection,  affecting  mainly
the  liver,  especially  the  right  lobe.
While  the  parasite  E.  multilocularis  causes  alveolar
echinococcosis,  it  is  E.  granulosis  infection  that  causes
(
n
[ydatid  cyst  formation.  These  can  be  asymptomatic  or  they
an  cause  pain,  secondary  infection,  or  rupture.  The  pres-Fig.  9)  and  is  thought  to  be  an  indirect  sign  of  commu-
ication  with  the  biliary  tree,  which  may  be  longstanding
28].
210  M.  Tekath  et  al.
Figure 9. Hydatid cyst in a patient originating from an endemic area. It is a well-delineated lesion, in which two components can be
distinguished, the ﬁrst being dependent ﬂuid (arrow) with high signal intensity on T2 (a) and T2 fat-sat sequences (b), and low signal
i , sho
T ce (b
a
C
T
ﬁ
d
s
o
i
a
w
r
D
T
c
Rntensity on T1 (c, d). The second component is fatty (arrowheads)
1 sequences (d), with marked signal drop on the T2 fat-sat sequen
rterial (f) or portal phase (g).
onclusion
he  presence  of  fat  in  a  hepatic  lesion  is  not  an  unusual
nding.  Identifying  the  fat  is  a  crucial  step  in  the  process  of
iagnosing  aetiology.  This  ﬁnding,  especially  when  demon-
trated  with  the  input  of  MRI,  points  to  different  groups
f  diagnoses  depending  on  whether  the  fat  component  is
ntracellular  or  extracellular.Considered  together  with  the  other  data  from  imaging
nd  the  clinical  context,  demonstration  of  a  fat  component
ithin  a  lesion  can  add  weight  to  a  theory  and  guide  the
adiologist  in  the  diagnostic  process.wing high signal intensity on T2 (a), in-phase (c) and out-of-phase
). No uptake after administration of contrast material either in the
isclosure of interest
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oncerning  this  article.
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